SHANGHAI BAO PHARMACEUTICALS CO., LTD. - B - H SHARES
(HKEX: 2659)
Shanghai Bao Pharmaceutical Co. Ltd. engages in the research and development of pharmaceutical products. It focuses on the following therapeutic areas: subcutaneous delivery, antibody-mediated auto-immune diseases, assisted reproduction, and synthetic biology upgrading platform. The company was founded by Yan Jun Liu and Zheng Wang on December 16, 2019 and is headquartered in Shanghai, China.
104.700 -
+2.500
(+2.45%)
Range
99.450 - 108.200
(8.80%)
Open
103.000
Previous Close
102.200
Bid Price
103.600
Bid Volume
('000)
0.1
Ask Price
104.700
Ask Volume
('000)
0.3
Volume
('000)
606.7
Value
62,966,713
Remark
-
Delayed prices. Updated at 29 Jan 2026 16:08.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
